Pyxis Oncology, Inc. — Form 10-Q
Filed August 13, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 12/100
What the filing says
This is a routine quarterly report filing (Form 10-Q) for the period ending June 30, 2026, filed August 13, 2026. The document header provides standard SEC filing metadata (accession number 0001193125-26-347913, 67 documents, company incorporated in Delaware, SIC code 2834 pharmaceutical preparations) but the actual financial and operational details are not extracted in the text provided.
Why this rating
No material transactions, guidance changes, or substantive events disclosed in provided text. Standard periodic SEC filing.
See more from August 13, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.